Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
Cerevel Therapeutics Announces The Appointment Of Dr. Ruth McKernan To Its Board Of Directors
By GlobeNewswire
Dec 8, 2020 7:00 AM EST
PRESS RELEASES
Cerevel Therapeutics To Host Investor Webcast Moderated By Stifel
By GlobeNewswire
Dec 4, 2020 7:00 AM EST
PRESS RELEASES
Cerevel Therapeutics To Present At The Evercore ISI 3rd Annual HealthCONx Virtual Conference
By GlobeNewswire
Nov 23, 2020 7:00 AM EST
PRESS RELEASES
Cerevel Therapeutics Announces First Patients Dosed In All Phase 3 Trials Of Tavapadon For The Treatment Of Parkinson's Disease
By GlobeNewswire
Oct 30, 2020 7:00 AM EDT
PRESS RELEASES
Cerevel Therapeutics Debuts As Publicly Traded Neuroscience Company
By GlobeNewswire
Oct 28, 2020 7:00 AM EDT
